Cathal Hayes

Cathal Hayes has a diverse work experience in corporate development and management roles in various companies. Cathal started their career in KPMG in 2006 as a Director, where they worked until 2014. Cathal then joined Adapt Pharma where they held several positions such as Director of Corporate Development, Senior Director of Corporate Development, and ultimately became the Vice President of Corporate Development. In 2018, Cathal Hayes joined Emergent BioSolutions as Vice President of Corporate Development.

Cathal Hayes obtained a Bachelor's degree in Accounting and Finance from University College Dublin during the years 2003 to 2006. Following their undergraduate studies, they pursued further education at Chartered Accountants Ireland, but specific details about their degree and field of study are not available. Additionally, they obtained a certification as a Chartered Accountant (ACA) from the Institute of Chartered Accountants, although the month and year of completion are unknown.